Overexpression of Pim-1 Is Associated With Poor Prognosis in Patients With Esophageal Squamous Cell Carcinoma

被引:52
作者
Liu, Hong-Tao [2 ]
Wang, Ning [3 ]
Wang, Xin [4 ]
Li, Sheng-Lei [1 ]
机构
[1] Zhengzhou Univ, Affiliated Hosp 1, Dept Pathol, Henan Key Lab Tumor Pathol, Zhengzhou 450052, Henan, Peoples R China
[2] Zhengzhou Univ, Dept Bioengn, Cell Biol Lab, Zhengzhou 450052, Henan, Peoples R China
[3] Henan Prov Med Res Inst, Zhengzhou, Peoples R China
[4] Zhengzhou Univ, Affiliated Hosp 1, Dept Oncol, Zhengzhou 450052, Henan, Peoples R China
关键词
provirus integration site for Moloney murine leukemia virus 1; esophageal squamous cell carcinoma; prognosis; immunohistochemistry; in situ hybridization; PROTEIN OVEREXPRESSION; PROTOONCOGENE PIM-1; KINASE; CANCER; SURVIVAL; PROGRESSION; EXPRESSION; APOPTOSIS; SURGERY; GENE;
D O I
10.1002/jso.21627
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Background and Objectives: It is well known that provirus integration site for Moloney marine leukemia virus I (Pim-1) plays an essential role in the occurrence and development of tumors. Here, we investigated expression of Pim-1 in esophageal squamous cell carcinoma (ESCC) and assessed the correlation between Pim-1 level and prognosis of the patients with ESCC Methods: Expression of Pim-1 was investigated by RT-PCR, immunohistochemistry, and in situ hybridization methods. Kaplan-Meier statistics was used to examine the relationship between levels of Pim-1 and prognosis using log-rank test. Results: The results demonstrated that ESCC tissues appeared strong expression levels of Pim-1 mRNA and protein while the normal esophageal tissues were either negative or showed only weak Pim-1 in RNA and protein levels. In addition, we found that Pim-1 expression was significantly correlated with histology grade. clinical staging, and lymph node metastasis (all P < 0 05), but not related to age and sex (all P > 0 05) Furthermore. the results of survival rates analyzed by Kaplan-Meier curve revealed that patients with high Pim-1 mRNA and protein expressions had a poorer prognosis than those with the low Pim-1 expression (P = 0.010 and 0.001. respectively). Conclusion: These findings demonstrate that Pim-1 may be used as molecular marker for predicting the prognosis of patients with ESCC. J Surg. Oncol. 2010;102:683-688 (C) 2010 Wiley-Liss, Inc.
引用
收藏
页码:683 / 688
页数:6
相关论文
共 39 条
[1]  
Beier UH, 2007, INT J ONCOL, V30, P1381
[2]   Chemoradiotherapy followed by surgery compared with surgery alone in squamous-cell cancer of the esophagus [J].
Bosset, JF ;
Gignoux, M ;
Triboulet, JP ;
Tiret, E ;
Mantion, G ;
Elias, D ;
Lozach, P ;
Ollier, JC ;
Pavy, JJ ;
Mercier, M ;
Sahmoud, T .
NEW ENGLAND JOURNAL OF MEDICINE, 1997, 337 (03) :161-167
[3]   Pim-1 plays a pivotal role in hypoxia-induced chemoresistance [J].
Chen, J. ;
Kobayashi, M. ;
Darmanin, S. ;
Qiao, Y. ;
Gully, C. ;
Zhao, R. ;
Yeung, S. C. ;
Lee, M. H. .
ONCOGENE, 2009, 28 (28) :2581-2592
[4]   Hypoxia-Mediated Up-Regulation of Pim-1 Contributes to Solid Tumor Formation [J].
Chen, Jian ;
Kobayashi, Masanobu ;
Darmanin, Stephanie ;
Qiao, Yi ;
Gully, Christopher ;
Zhao, Ruiying ;
Kondo, Satoshi ;
Wang, Hua ;
Wang, Huamin ;
Yeung, Sai-Ching Jim ;
Lee, Mong-Hong .
AMERICAN JOURNAL OF PATHOLOGY, 2009, 175 (01) :400-411
[5]   Pim kinase inhibitor, SGI-1776, induces apoptosis in chronic lymphocytic leukemia cells [J].
Chen, Lisa S. ;
Redkar, Sanjeev ;
Bearss, David ;
Wierda, William G. ;
Gandhi, Varsha .
BLOOD, 2009, 114 (19) :4150-4157
[6]   Clinical Significance of the Expression of Galectin-3 and Pim-1 in Laryngeal Squamous Cell Carcinoma [J].
Choi, Ji Yun ;
Cho, Sung Il ;
Do, Nam Yong ;
Kang, Cha Young ;
Lim, Sung Chul .
JOURNAL OF OTOLARYNGOLOGY-HEAD & NECK SURGERY, 2010, 39 (01) :28-34
[7]   Overexpression of Pim-1 during progression of prostatic adenocarcinoma [J].
Cibull, TL ;
Jones, TD ;
Li, L ;
Eble, JN ;
Baldridge, LA ;
Malott, SR ;
Luo, Y ;
Cheng, L .
JOURNAL OF CLINICAL PATHOLOGY, 2006, 59 (03) :285-288
[8]  
CUYPERS HT, 1984, CELL, V37, P141
[9]   Myc-driven murine prostate cancer shares molecular features with human prostate tumors [J].
Ellwood-Yen, K ;
Graeber, TG ;
Wongvipat, J ;
Iruela-Arispe, ML ;
Zhang, JF ;
Matusik, R ;
Thomas, GV ;
Sawyers, CL .
CANCER CELL, 2003, 4 (03) :223-238
[10]   Medical progress - Esophageal cancer [J].
Enzinger, PC ;
Mayer, RJ .
NEW ENGLAND JOURNAL OF MEDICINE, 2003, 349 (23) :2241-2252